ELI LILLY AND COMPANY

NYSE: LLY (Eli Lilly and Company)

最近更新时间: 昨天, 12:24PM

1,444.74

1.24 (0.09%)

前收盘价格 1,443.50
成交量 1,430,488
预期市盈率 (P/E Forward) 29.01
价格/销量 (P/S) 14.95
股市价格/股市净资产 (P/B) 31.94
52周波幅
850.51 (-41%) — 1,475.25 (2%)
股息率 (DY TTM) 0.63%
营业毛利率 22.67%
营业利益率 (TTM) 42.49%
稀释每股收益 (EPS TTM) 12.27
季度收入增长率 (YOY) 45.20%
季度盈利增长率 (YOY) 23.00%
总债务/股东权益 (D/E MRQ) 243.61%
流动比率 (MRQ) 1.37
营业现金流 (OCF TTM) 9.32 B
杠杆自由现金流 (LFCF TTM) -1.82 B
资产报酬率 (ROA TTM) 16.45%
股东权益报酬率 (ROE TTM) 77.28%

AIStockmoo 评分

0.7
价值 30% 1.2
来自我们的 AI Insight 报告对预期回报与风险的评估。 参考 NA
相对其盈利增长,估值偏低。 参考
当前股价隐含每年 22.3% 的盈利增长;公司业务可支撑约每年 15.0% 的增长。 参考
接近其一贯估值。 参考
负债高。盈利能力强。现金流为负。 参考
资本回报远高于资本成本。资本回报上升。 参考
时机 30% 3.1
来自我们对走势图的 AI 技术分析。 参考 NA
过去一年呈上升趋势。股价接近52周高点。 参考
近期出现看跌反转形态:射击之星。 参考
您持有期的趋势 参考 NA
市场情绪 20% 0.0
近期没有目标价,因此依据目标价的调整方向。 参考
近期新闻好坏参半或中性。 参考
聪明钱 20% -2.7
多名内部人士近期净卖出。股价高于内部人士的卖出价。 参考
机构在最新13F申报中净-23.90%的股份:2,501家增持,1,954家减持(截至30 Sep 2026的季度)。 参考
市场和行业状况中性。
市场环境偏谨慎。 参考
行业表现优于大市。
各支柱方向不一,评分因此减弱。
不计入评分
股价高于其52周平均水平。5年来上涨。 参考
短、中、长期趋势均向上。短期动能上升。 参考
股价接近阻力位。支撑与阻力水平趋降。 参考
最终评分 0.70

市场趋势

短期 中期
行业 Drug Manufacturers - General (US) 混合的 看涨
Drug Manufacturers - General (全球的) 混合的 看涨
股票 Eli Lilly and Company 混合的 看涨

相关股票

股票 市值 DY P/E(TTM) P/B
LLY - 0.63% - 31.94
NVS - 3.20% - 8.13
MRK - 2.31% - 8.12
JNJ - 1.92% - 8.44
PFE - 6.00% - 1.85
ABBV - 3.18% - -

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

部门 Healthcare
行业 Drug Manufacturers - General
投资方式 Large Growth
内部持股比例 0.16%
机构持股比例 83.96%

所有权

姓名 日期 持有股份
Lilly Endowment Inc 30 Sep 2026 90,066,978
Pnc Financial Services Group, Inc. 30 Sep 2026 51,295,197

该时间范围内无数据。

名称 平均购买 ($) 平均卖出 ($) 总净额 总净值 ($)
JONSSON PATRIK - 1,432.29 -704 -1,008,332
RICKS DAVID A - 1,409.38 -23,538 -33,173,986
累积净数量 -24,242
累积净值 ($) -34,182,319
累积平均购买 ($) -
累积平均卖出 ($) 1,410.05
名称 持有人 日期 类型 数量 价格 价值 ($)
JONSSON PATRIK 职员 10 Nov 2026 处理 (-) 704 1,432.29 1,008,332
RICKS DAVID A 职员 03 Nov 2026 处理 (-) 23,538 1,409.38 33,173,986

机构

机构持股比例: 98.05%

持仓变动 机构数 股数
增持 2,501 29,582,823
减持 1,954 194,259,902
新建仓 246 6,746,969
清仓 175 66,935,014

来源:经Nasdaq的SEC 13F申报,最新申报截至30 Sep 2026。申报在每季结束后45天内陆续提交。

3 正面 4 负面 8 中性
日期 类型 细节
16 Nov 2026 Yahoo Finance Lilly Bets Up to $1.5 Billion on Calytrix's Preclinical Antibody
The deal is Lilly's second blood cancer acquisition this year, after Ajax Therapeutics…
16 Nov 2026 Yahoo Finance Eli Lilly Makes $1.5 Billion Move Beyond Weight-Loss Drugs
Calytrix is developing an early-stage antibody treatment for essential thrombocythemia and myelofibrosis.
16 Nov 2026 Yahoo Finance Eli Lilly is trouncing Nvidia — and the weight-loss drug trade is beating AI again
Since its Oct. 6 record, Nvidia has shed more than $1.7 trillion in market value. Eli Lilly has added more than $250 billion over the same stretch, a gain topped only by Apple among the market's biggest stocks.
16 Nov 2026 Yahoo Finance CVS Sees a Possible Break-Even Point for GLP-1s
Drugmakers could gain patients while earning less per prescription.
16 Nov 2026 Yahoo Finance CVS white paper aims to pressure drugmakers to lower GLP-1 prices
GLP-1s would save employers money in the long term if priced at $350 a month or less, the company found. “I would love to see this pressure [drugmakers] to bring down prices to something rational,” CMO Amy Compton-Phillips said.
16 Nov 2026 Yahoo Finance Anti-Obesity Drugs Market Companies Analysis 2027: Eli Lilly and Novo Nordisk Lead as Pfizer, Roche and Amgen Invest Billions to Challenge Them in a Market Headed for USD 64.96 Billion by 2035
Lilly's Mounjaro and Zepbound Earn USD 16.1 Billion in One Quarter, Novo's Obesity Sales Rise 22% and Oral GLP-1 Pills Open a New Front: Precedence Research Company Intelligence on Leaders, Pipelines, Investments and DealsOttawa, Nov. 16, 2026 (GLOBE NEWSWIRE) -- The global anti-obesity drugs…
16 Nov 2026 Yahoo Finance Eli Lilly to acquire Calytrix Bio in deal worth up to $1.5 billion
Eli Lilly and Co (NYSE:LLY) has agreed to acquire privately held biotechnology company Calytrix Bio for up to $1.5 billion in cash, expanding its efforts to develop treatments for rare blood disorders and strengthen its presence in haematology. Under the definitive agreement, Calytrix…
16 Nov 2026 Yahoo Finance Eli Lilly to Acquire Calytrix Bio for Up to $1.5 Billion to Expand Blood Cancer Portfolio
Eli Lilly and Company (NYSE:LLY) has agreed to acquire privately held biotechnology company Calytrix Bio in a cash transaction valued at up to $1. 5 billion, expanding its development portfolio of treatments for rare blood cancers.
16 Nov 2026 Yahoo Finance Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
Lilly (LLY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
16 Nov 2026 Yahoo Finance Lilly adds to buyout streak with $1.5B purchase of startup Calytrix
Lilly’s 15th announced company acquisition this year — by far the most in the biopharmaceutical sector — centers around a precision therapy for rare blood disorders known as myeloproliferative neoplasms.
16 Nov 2026 Yahoo Finance What Does Eli Lilly (LLY) Reveal At ObesityWeek 2026 About Its Growth Path?
Eli Lilly (NYSE:LLY) released new clinical data at ObesityWeek 2026 on Zepbound, Foundayo, EloraTZP, and retatrutide. The update included late-stage obesity and cardiometabolic results that covered weight loss, metabolic markers, and related chronic conditions. Data presented highlighted efficacy…
16 Nov 2026 Yahoo Finance State Street Health Care SPDR (XLV) Sells Eli Lilly and J&J on Nov. 12
The fund sold $300.3 million of stock, cutting all 60 positions and adding nothing, as its assets stood at $50.56 billion.
16 Nov 2026 Yahoo Finance ETFs Are Net Sellers of Eli Lilly (LLY) on Nov. 12
Eli Lilly (LLY) drew $300.9 million in net ETF selling Thursday.
16 Nov 2026 Yahoo Finance Big-name investors pour $100M into DNA therapeutics developer Seawolf
The startup, which also just disclosed an up to $1.2 billion partnership with Sanofi, is backed by Versant, MPM BioImpact, Eli Lilly and Novartis’ venture arm.
09 Nov 2026 CNBC Eli Lilly’s Foundayo obesity pill eases sleep apnea in late-stage trial, paving way for approval
Lilly plans to file by the end of the year for U.S. approval of the daily pill for moderate-to-severe obstructive sleep apnea in adults with obesity.
02 Oct 2026 CNBC Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
30 Sep 2026 CNBC Eli Lilly says closely watched combo obesity regimen boosts weight loss in mid-stage trial
30 Sep 2026 CNBC People switching to Novo's Wegovy pill from obesity injections kept losing weight in real-world study 
25 Sep 2026 CNBC Novo is betting on its next chapter as Eli Lilly gains more ground in GLP-1s
21 Sep 2026 CNBC Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
21 Sep 2026 CNBC Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
14 Sep 2026 CNBC Novo CEO tells CNBC why drugmaker is rebranding, needs to 'rethink' obesity strategy
31 Aug 2026 CNBC Trump strikes new drug pricing deals with nine midsized drugmakers
显示更多
股息率 (DY TTM) 0.63%
5年平均股息收益率 0.78%
股息支付比率 43.94%
除息日 公告日期 支付日期 详情
14 Feb 2025 09 Dec 2024 10 Mar 2025 1.5 现金
15 Nov 2024 28 Oct 2024 10 Dec 2024 1.3 现金
15 Aug 2024 24 Jun 2024 10 Sep 2024 1.3 现金
15 May 2024 06 May 2024 10 Jun 2024 1.3 现金
14 Feb 2024 08 Dec 2023 08 Mar 2024 1.3 现金
14 Nov 2023 01 Nov 2023 08 Dec 2023 1.13 现金
14 Aug 2023 26 Jun 2023 08 Sep 2023 1.13 现金
12 May 2023 01 May 2023 09 Jun 2023 1.13 现金
14 Feb 2023 12 Dec 2022 10 Mar 2023 1.13 现金
14 Nov 2022 17 Oct 2022 09 Dec 2022 0.98 现金
12 Aug 2022 27 Jun 2022 09 Sep 2022 0.98 现金
13 May 2022 02 May 2022 10 Jun 2022 0.98 现金
14 Feb 2022 13 Dec 2021 10 Mar 2022 0.98 现金
12 Nov 2021 18 Oct 2021 10 Dec 2021 0.85 现金
12 Aug 2021 29 Jun 2021 10 Sep 2021 0.85 现金
13 May 2021 03 May 2021 10 Jun 2021 0.85 现金
11 Feb 2021 14 Dec 2020 10 Mar 2021 0.85 现金
12 Nov 2020 19 Oct 2020 10 Dec 2020 0.74 现金
13 Aug 2020 15 Jul 2020 10 Sep 2020 0.74 现金
14 May 2020 04 May 2020 10 Jun 2020 0.74 现金
13 Feb 2020 16 Dec 2019 10 Mar 2020 0.74 现金
14 Nov 2019 22 Oct 2019 10 Dec 2019 0.645 现金
14 Aug 2019 20 Jun 2019 10 Sep 2019 0.645 现金
16 May 2019 07 May 2019 10 Jun 2019 0.645 现金
14 Feb 2019 19 Dec 2018 08 Mar 2019 0.645 现金
14 Nov 2018 16 Oct 2018 10 Dec 2018 0.5625 现金
14 Aug 2018 19 Jun 2018 10 Sep 2018 0.5625 现金
16 May 2018 07 May 2018 08 Jun 2018 0.5625 现金
14 Feb 2018 11 Dec 2017 09 Mar 2018 0.5625 现金
14 Nov 2017 16 Oct 2017 08 Dec 2017 0.52 现金
11 Aug 2017 19 Jun 2017 08 Sep 2017 0.52 现金
11 May 2017 01 May 2017 09 Jun 2017 0.52 现金
13 Feb 2017 12 Dec 2016 10 Mar 2017 0.52 现金
10 Nov 2016 17 Oct 2016 09 Dec 2016 0.51 现金
11 Aug 2016 20 Jun 2016 09 Sep 2016 0.51 现金
11 May 2016 02 May 2016 10 Jun 2016 0.51 现金
10 Feb 2016 08 Dec 2015 10 Mar 2016 0.51 现金
10 Nov 2015 19 Oct 2015 10 Dec 2015 0.5 现金
12 Aug 2015 15 Jun 2015 10 Sep 2015 0.5 现金
14 May 2015 04 May 2015 10 Jun 2015 0.5 现金
11 Feb 2015 15 Dec 2014 10 Mar 2015 0.5 现金
12 Nov 2014 20 Oct 2014 10 Dec 2014 0.49 现金
13 Aug 2014 16 Jun 2014 10 Sep 2014 0.49 现金
13 May 2014 05 May 2014 10 Jun 2014 0.49 现金
12 Feb 2014 16 Dec 2013 10 Mar 2014 0.49 现金
13 Nov 2013 21 Oct 2013 10 Dec 2013 0.49 现金
13 Aug 2013 18 Jun 2013 10 Sep 2013 0.49 现金
14 May 2013 03 May 2013 10 Jun 2013 0.49 现金
13 Feb 2013 17 Dec 2012 08 Mar 2013 0.49 现金
13 Nov 2012 15 Oct 2012 10 Dec 2012 0.49 现金
13 Aug 2012 19 Jun 2012 10 Sep 2012 0.49 现金
13 Feb 2012 12 Dec 2011 09 Mar 2012 0.49 现金
10 Nov 2011 17 Oct 2011 09 Dec 2011 0.49 现金
11 Aug 2011 20 Jun 2011 09 Sep 2011 0.49 现金
11 May 2011 18 Apr 2011 10 Jun 2011 0.49 现金
11 Feb 2011 13 Dec 2010 10 Mar 2011 0.49 现金
10 Nov 2010 18 Oct 2010 10 Dec 2010 0.49 现金
11 Aug 2010 21 Jun 2010 10 Sep 2010 0.49 现金
12 May 2010 19 Apr 2010 10 Jun 2010 0.49 现金
10 Feb 2010 14 Dec 2009 10 Mar 2010 0.49 现金
10 Nov 2009 19 Oct 2009 10 Dec 2009 0.49 现金
12 Aug 2009 22 Jun 2009 10 Sep 2009 0.49 现金
13 May 2009 20 Apr 2009 10 Jun 2009 0.49 现金
11 Feb 2009 15 Dec 2008 10 Mar 2009 0.49 现金
12 Nov 2008 20 Oct 2008 10 Dec 2008 0.47 现金
13 Aug 2008 20 Jun 2008 10 Sep 2008 0.47 现金
13 Feb 2008 17 Dec 2007 10 Mar 2008 0.47 现金
13 Nov 2007 15 Oct 2007 10 Dec 2007 0.425 现金
13 Aug 2007 21 Jun 2007 10 Sep 2007 0.425 现金
11 May 2007 16 Apr 2007 08 Jun 2007 0.425 现金
13 Feb 2007 18 Dec 2006 09 Mar 2007 0.425 现金
13 Nov 2006 16 Oct 2006 08 Dec 2006 0.4 现金
11 Aug 2006 26 Jun 2006 08 Sep 2006 0.4 现金
11 May 2006 24 Apr 2006 09 Jun 2006 0.4 现金
13 Feb 2006 19 Dec 2005 10 Mar 2006 0.4 现金
10 Nov 2005 17 Oct 2005 09 Dec 2005 0.38 现金
11 Aug 2005 24 Jun 2005 09 Sep 2005 0.38 现金
11 May 2005 18 Apr 2005 10 Jun 2005 0.38 现金
11 Feb 2005 20 Dec 2004 10 Mar 2005 0.38 现金
10 Nov 2004 18 Oct 2004 10 Dec 2004 0.355 现金
11 Aug 2004 28 Jun 2004 10 Sep 2004 0.355 现金
12 May 2004 19 Apr 2004 10 Jun 2004 0.355 现金
11 Feb 2004 15 Dec 2003 10 Mar 2004 0.355 现金
12 Nov 2003 20 Oct 2003 10 Dec 2003 0.335 现金
13 Aug 2003 23 Jun 2003 10 Sep 2003 0.335 现金
13 May 2003 28 Apr 2003 10 Jun 2003 0.335 现金
12 Feb 2003 16 Dec 2002 10 Mar 2003 0.335 现金
13 Nov 2002 21 Oct 2002 10 Dec 2002 0.31 现金
13 Aug 2002 24 Jun 2002 10 Sep 2002 0.31 现金
13 May 2002 15 Apr 2002 10 Jun 2002 0.31 现金
13 Feb 2002 17 Dec 2001 08 Mar 2002 0.31 现金
13 Nov 2001 15 Oct 2001 10 Dec 2001 0.28 现金
13 Aug 2001 25 Jun 2001 10 Sep 2001 0.28 现金
11 May 2001 16 Apr 2001 11 Jun 2001 0.28 现金
13 Feb 2001 18 Dec 2000 09 Mar 2001 0.28 现金
13 Nov 2000 16 Oct 2000 11 Dec 2000 0.26 现金
11 Aug 2000 26 Jun 2000 11 Sep 2000 0.26 现金
11 May 2000 17 Apr 2000 09 Jun 2000 0.26 现金
11 Feb 2000 20 Dec 1999 10 Mar 2000 0.26 现金
10 Nov 1999 18 Oct 1999 10 Dec 1999 0.23 现金
11 Aug 1999 19 Jul 1999 10 Sep 1999 0.23 现金
12 May 1999 19 Apr 1999 10 Jun 1999 0.23 现金
10 Feb 1999 21 Dec 1998 10 Mar 1999 0.23 现金
10 Nov 1998 20 Oct 1998 10 Dec 1998 0.2 现金
12 Aug 1998 20 Jul 1998 10 Sep 1998 0.2 现金
13 May 1998 20 Apr 1998 10 Jun 1998 0.2 现金
11 Feb 1998 15 Dec 1997 10 Mar 1998 0.2 现金
12 Nov 1997 15 Sep 1997 10 Dec 1997 0.2 现金
13 Aug 1997 21 Jul 1997 10 Sep 1997 0.36 现金
13 May 1997 21 Apr 1997 10 Jun 1997 0.36 现金
12 Feb 1997 16 Dec 1996 10 Mar 1997 0.36 现金
13 Nov 1996 21 Oct 1996 10 Dec 1996 0.3425 现金
13 Aug 1996 15 Jul 1996 10 Sep 1996 0.3425 现金
13 May 1996 15 Apr 1996 10 Jun 1996 0.3425 现金
13 Feb 1996 18 Dec 1995 11 Mar 1996 0.3425 现金
13 Nov 1995 17 Oct 1995 11 Dec 1995 0.685 现金
11 Aug 1995 17 Jul 1995 11 Sep 1995 0.645 现金
09 May 1995 17 Apr 1995 12 Jun 1995 0.645 现金
显示更多

每年股息收益率

年份 每年总股息 ($) 频率/年份 收益率 %
2025 1.50 1 0.14
2024 5.20 4 0.67
2023 4.52 4 0.78
2022 3.92 4 1.07
2021 3.40 4 1.23
2020 2.96 4 1.75
2019 2.58 4 1.96
2018 2.25 4 1.94
2017 2.08 4 2.46
2016 2.04 4 2.77
2015 2.00 4 2.37
2014 1.96 4 2.84
2013 1.96 4 3.84
2012 1.47 3 2.98
2011 1.96 4 4.72
2010 1.96 4 5.59
2009 1.96 4 5.49
2008 1.41 3 3.50
2007 1.70 4 3.18
2006 1.60 4 3.07
2005 1.52 4 2.69
2004 1.42 4 2.50
2003 1.34 4 1.91
2002 1.24 4 1.95
2001 1.12 4 1.43
2000 1.04 4 1.12
1999 0.920 4 1.38
1998 0.800 4 0.90
1997 1.28 4 1.84
1996 1.37 4 3.75
1995 1.98 3 7.02
显示更多

近期信号 K线形态与EMA交叉

▼ 射击之星 上一个交易日 · 16 Nov
上涨后,买方一度大幅推高股价但未能守住,收盘接近最低价。看跌反转信号。

AI 技术分析

投资组合

AI 建议策略模板

自定义的价格提醒

风险概况

| | | | |
很保守
适度保守
中等
中等风险
激进风险
安全边际 (EP)
部分利润 (TP1)
目标利润 (TP2)
最大损失 (SL)

免责声明:以上内容仅供参考,并非投资建议。请咨询合格的财务顾问。

开始购买价格 (EP)

第一个目标价格赚取利润 (TP1)

第二个目标价格赚取利润 (TP2)

停止损失价格 (SL)

52周波幅范围
 
52WL
 
52WH
SL
EP
TP1
TP2

所有提醒价格都在52周波幅范围内

已实现利润 -
未实现利润 -
收到股息 2026 -
利润总额 -
平均回报 -
数量(购买) -
平均价格(购买) -
数量(卖出) -
平均价格(卖出) -
没有符合您标准的股票